Related Experiment Video
Updated: Aug 23, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Association of plasma bone morphogenetic protein-4 levels with arterial stiffness in hypertensive patients
Ning Wang1,2, Ying Guo1,2, Ying Dong1,3,4
1Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Insights
Plasma levels of bone morphogenetic protein-4 (BMP-4) are higher in hypertensive individuals with arterial stiffness. Elevated BMP-4 indicates increased arterial stiffness, suggesting its potential as a predictive marker.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Hypertension Studies
Background:
- Arterial stiffness is an early indicator of hypertension-related organ damage.
- Bone morphogenetic protein-4 (BMP-4) may play a role in the interaction between hypertension and arterial stiffness.
Purpose of the Study:
- To investigate the association between plasma BMP-4 concentrations and arterial stiffness in individuals with essential hypertension.
- To determine if BMP-4 levels can predict arterial stiffness in hypertensive patients.
Main Methods:
- 204 hypertensive individuals were categorized into high (abnormal) and low (normal) cardio-ankle vascular index (CAVI) groups.
- Plasma BMP-4 levels were measured using ELISA.
- Clinical characteristics and laboratory data were collected and analyzed.
Main Results:
- Plasma BMP-4 levels were significantly higher in the high CAVI group compared to the low CAVI group.
- BMP-4 concentrations showed a positive correlation with CAVI values in hypertensive individuals.
- Elevated BMP-4 levels were independently associated with high CAVI, with a cutoff value of 33.34 pg/mL demonstrating predictive capability (AUC 0.751).
Conclusions:
- Plasma BMP-4 levels are elevated in hypertensive individuals with increased arterial stiffness (high CAVI).
- BMP-4 shows a strong correlation with CAVI, suggesting its potential as a predictive biomarker for arterial stiffness in hypertension.
Background:
Arterial stiffness interacts with hypertension, becoming an early marker of hypertension-mediated target organ damage. This study aimed to assess the association between plasma concentrations of bone morphogenetic protein-4 (BMP-4) and arterial stiffness during hypertension.
Methods:
Using cardio-ankle vascular index (CAVI) to determine arterial stiffness status, 204 individuals with essential hypertension were classified into two groups, high CAVI (abnormal) group (n = 94) and low (normal) CAVI group (n = 110). Data were collected including clinical characteristics and laboratory measurements. Plasma levels of BMP-4 were tested by using ELISA analysis.
Results:
Plasma levels of BMP-4 were substantially greater in high CAVI group than that in low CAVI group [38.51 (31.79-50.83) pg/mL vs. 31.15 (29.38-32.37) pg/mL; p < 0.001]. As shown by spearman correlation analysis, BMP-4 concentrations were correlated with CAVI values in hypertensive individuals (r = 0.406, p < 0.001). After adjustment for potential confounders, elevated BMP-4 levels were related with high CAVI (OR, 1.070; 95% CI, 1.003-1.108; p < 0.001). The best BMP-4 cutoff value for identifying high CAVI, as determined by ROC curve analysis, was 33.34 pg/mL (AUC, 0.751; 95% CI, 0.683-0.818; p < 0.001).
Conclusion:
Plasma levels of BMP-4 are increased in hypertensive individuals with high CAVI. Elevated BMP-4 levels are strongly correlated with higher CAVI values, implying a predictive value of BMP-4 in arterial stiffness during hypertension.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Assessment of blood pressure in brachial artery(two-step method)
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Pre-Procedural Guidelines for Assessing Blood Pressure

